Presenting a new paradigm in cancer therapy: delivering therapeutic agents using navigable microcarriers

IEEE Pulse
|May 20, 2014
PubMed

Insights

Cancer, characterized by uncontrolled cell growth, affects millions globally. Research is crucial for developing improved cancer treatment modalities to combat rising incidence and mortality rates.

Area of Science:

  • Oncology
  • Cancer Research

Background:

  • Cancer is defined as the uncontrolled growth and spread of abnormal cells.
  • Cancer incidence and mortality rates are increasing globally.
  • In 2013, the U.S. reported an estimated 1,660,290 new cancer cases and 580,350 deaths.

Purpose of the Study:

  • To highlight the global burden of cancer.
  • To emphasize the critical need for novel and enhanced cancer treatment strategies.

Main Methods:

  • Statistical data from the American Cancer Society for 2013 was analyzed.
  • Global population data was considered to contextualize cancer prevalence.

Main Results:

  • Lifetime cancer risk in the U.S. is nearly 1 in 2 for men and over 1 in 3 for women.
  • Cancer causes approximately 1,600 deaths daily in the U.S.

Conclusions:

  • The significant and growing impact of cancer necessitates urgent advancements in treatment.
  • Further research into innovative cancer therapies is essential to address this global health challenge.

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
159
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.3K